Friday 9th December 2022

Agenda

1. Minutes from the 80th ACAF meeting – Members will review the minutes from the last meeting and provide comments on any changes needed. ACAF/81/01
2. Dossier for assessment: RP709 ProAct 360. ACAF/81/02 
3. Dossier for assessment: RP746 Agal-Pro. ACAF/81/03 
4. Dossier for assessment: RP748 Coxam. ACAF/81/04
5. Dossier for assessment: RP791 Lactobacillus buchneri. ACAF/81/05
6. Response to RFI: RP1071 – Members will revisit the efficacy query presented by the applicant. ACAF/81/06 
7. Response to RFI: RP226 – Members will revisit the applicant’s response to the Committee’s request. ACAF/81/07 
8. Response to RFI: RP416 – Members will revisit the applicant’s response to the Committee’s request. ACAF/81/08
9. Response to RFI: RP666 – Members will revisit the applicant’s response to the Committee’s request. ACAF/81/09
10. Response to RFI: RP686 – Members will revisit the applicant’s response to the Committee’s request. ACAF/81/10
11. Draft opinion – RP557,600 – RP140,141,142,284, RP641 - Members will evaluate the draft opinions and provide feedback on the content of the document. Members will also finalise previous opinions presented to the Committee. ACAF/81/11
12. Committee’s workload and expertise – Members will receive a briefing by the Chair and Secretariat on the results from the enquiries on workloads and expertise. ACAF/81/12 
13. Nanoparticles – A presentation will be given on the FSA’s approach to nanoparticles assessment and their importance in absorption processes and pharmacokinetics. ACAF/81/13 
14. FSA ongoing research update – Members will receive a presentation updating progress on the FSA lines of research. ACAF/81/14
15. Any other business: Sharing information of interest to other ACAF members. ACAF/81/AOB 

Minutes

Minutes of the 81st ACAF meeting held on Friday 9th December 2022